Crofelemer

CHEMBL2108184 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

A plant-derived medication made from the red latex of the croton tree, used to treat non-infectious diarrhea in HIV/AIDS patients taking antiretroviral therapy. It works locally in the gut by blocking chloride ion channels in intestinal cells, reducing excess fluid secretion. Because it is minimally absorbed into the bloodstream, it has few systemic side effects.

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A plant-derived medication made from the red latex of the croton tree, used to treat non-infectious diarrhea in HIV/AIDS patients taking antiretroviral therapy. It works locally in the gut by blocking chloride ion channels in intestinal cells, reducing excess fluid secretion. Because it is minimally absorbed into the bloodstream, it has few systemic side effects.

Yes, Crofelemer is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108184. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.